Status:
COMPLETED
Azole-resistance in Aspergillus
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Pulmonary Aspergillosis
Eligibility:
All Genders
Brief Summary
Prospective multi-center surveillance study on the prevalence of azole-resistant Aspergillus spp. in clinical isolates of patients with pulmonary colonization or invasive infections in Switzerland
Detailed Description
Azole-resistance in Aspergillus (A.) fumigatus has emerged as a global health problem. Even more, it has been associated with high mortality rates in patients with invasive aspergillosis. Generally, ...
Eligibility Criteria
Inclusion
- Available respiratory sample growing Aspergillus spp.
- Available clinical data
Exclusion
- • refusal to sign the general consent
Key Trial Info
Start Date :
June 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 2 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03443336
Start Date
June 1 2017
End Date
June 2 2021
Last Update
June 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Infectious Diseases and Hospital Epidemiology
Basel, Switzerland, 4031